Core One Labs Inc (COOL.CX)
0.23
0.00 (0.00%)
CAD |
CNSX |
May 02, 16:00
Core One Labs Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 2.610M |
September 30, 2022 | -0.5955M |
June 30, 2022 | 0.3242M |
March 31, 2022 | 0.7962M |
December 31, 2021 | 3.585M |
September 30, 2021 | 4.852M |
June 30, 2021 | 6.762M |
March 31, 2021 | 7.135M |
December 31, 2020 | 4.433M |
September 30, 2020 | 4.863M |
June 30, 2020 | 1.871M |
March 31, 2020 | 5.56M |
December 31, 2019 | 6.338M |
September 30, 2019 | 7.880M |
June 30, 2019 | 7.615M |
March 31, 2019 | 11.98M |
December 31, 2018 | 15.50M |
September 30, 2018 | 17.59M |
June 30, 2018 | 18.69M |
March 31, 2018 | 18.48M |
December 31, 2017 | 15.13M |
September 30, 2017 | 12.20M |
June 30, 2017 | 12.90M |
Date | Value |
---|---|
March 31, 2017 | 4.073M |
December 31, 2016 | 2.988M |
September 30, 2016 | 2.235M |
June 30, 2016 | 0.5931M |
March 31, 2016 | 1.171M |
December 31, 2015 | 1.164M |
September 30, 2015 | 0.6404M |
June 30, 2015 | 0.6518M |
March 31, 2015 | 0.37M |
December 31, 2014 | 0.37M |
September 30, 2014 | 0.5113M |
June 30, 2014 | 0.5112M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.0008M |
June 30, 2013 | 0.0008M |
March 31, 2013 | 0.0008M |
December 31, 2012 | 0.00 |
September 30, 2012 | -0.0402M |
June 30, 2012 | 0.5286M |
March 31, 2012 | 0.5286M |
December 31, 2011 | 0.5293M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.5955M
Minimum
Sep 2022
7.880M
Maximum
Sep 2019
4.269M
Average
4.852M
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
Biocure Technology Inc | 0.3224M |
Nova Mentis Life Science Corp | -- |
Nanosphere Health Sciences Inc | -- |
Lobe Sciences Ltd | 1.527M |
Algernon Pharmaceuticals Inc | 2.158M |